Backs FY25 adjusted EBITDA view $475M-$505M. The company said, “Based on our year-to-date performance and outlook for the fourth quarter, Visteon (VC) is maintaining its full-year 2025 guidance range of $3.70 – $3.85 billion, adjusted EBITDA of $475 – $505 million, and adjusted free cash flow of $195 – $225 million. Adjusted EBITDA and adjusted free cash flow are tracking towards the high end of the ranges while sales are tracking below the midpoint. Our guidance does not contemplate any potential impact of Nexperia supply disruptions on both Visteon and the automotive industry.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VC:
